The influence of goutweed (Aegopodium podagraria L.) tincture and metformin on the histopathological changes of the internal organs in dyslipidemic rats
DOI:
https://doi.org/10.24959/ubphj.17.92Keywords:
rats, goutweed, dyslipidemia, kidney, liver, heartAbstract
Topicality. Combined use of herbal originated substances with the conventional drugs is a promising area of therapy improvement. The tincture and the extract obtained from goutweed (Aegopodium podagraria L.) are able to normalize
carbohydrate and lipid metabolism, the tincture partially increases the efficacy of metformin in the experiment. The aim of this study was to evaluate the influence of goutweed tincture and the extract as well as their combinations
with metformin on the histological structure of the internal organs of rats with lipid metabolism disorders.
Materials and methods. Combined use of atherogenic diet and protamine sulfate administration was applied.
Results and discussion. In the untreated group the histological examination allowed identifying the changes in kidneys (granular dystrophy of tubular epithelium, focal perivascular lymphocytic infiltration, focal sclerosis of the arterial walls); heart (granular dystrophy of cardiomyocytes, perivascular sclerotic with limited lymphohistiocytic infiltration and foci of ischemic changes in myocardium); liver (expressed granular dystrophy of hepatocytes, widening of space of Disse, signs of compensatory hypertrophy); while there were no changes in aorta. Metformin (50 mg/kg intragastrically) failed to demonstrate a normalizing influence on the liver structure, and necrobiosis and vacuolar dystrophy of hepatocytes were evident, it did not influence significantly of the kidney structure, and exerted a protective effect on the structure of the blood vessels of the heart, still not eliminating ischemic changes. Goutweed extract (1 g/kg intragastrically) and the tincture (1 ml/kg intragastrically) counteracted the changes in the structure of the kidney vessels and myocardium, including ischemic changes, while the liver histopathological changes were similar to those in metformin group. After combined administration of goutweed tincture and metformin as well as the extract and metformin at doses stated above the protective activity in regard to the heart structure was maintained, against the background of metformin with the tincture such activity in regard to the kidney structure was also evident; the toxicity of the investigated drugs was not enhanced, and there was no increase in the severity of the liver changes.
Conclusions. Further ivestigation of goutweed preparations with metformin is expedient.
References
Efferth, T. Complex interactions between phytochemicals. The multi–target therapeutic concept of phytotherapy / T. Efferth, E. Koch // Curr. Drug
Targets. – 2011. – Vol. 12, Issue 1. – P. 122–132. doi: 10.2174/138945011793591626
New perspectives on how to discover drugs from herbal medicines: CAM’S outstanding contribution to modern therapeutics / S. Y. Pan, S. F. Zhou,
S. H. Gao et al. // Evid. Based Complement Alternat. Med. – 2013. – Vol. 2013. doi: 10.1155/2013/627375
Handbook of medicinal herbs / J. A. Duke, M. J. Bogenschutz–Godwin, P. duCellier, P.–A. Duke. – Boca Raton: CRC Press, 2002. – P. 346.
Койро, О. О. Роль біологічно активних речовин яглиці звичайної (Aegopodium podagraria L.) у нефропротекторній, гепатопротекторній
та гіпоурикемічній дії : автореф. дис. ... канд. фарм. наук. – Х., 2014. – 20 с.
Товчига, О. В. Дослідження сечогінної, нефропротекторної, гіпоурикемічної дії яглиці звичайної (Aegopodium podagraria L.) як основа
для створення лікарських засобів : автореф. дис. ... канд. фарм. наук. – Х., 2009. – 21 с.
Товчига, О. В. Вплив препаратів яглиці звичайної (Aegopodium podagraria L.) на метаболічні процеси в мишей із алоксановим цукровим
діабетом / О. В. Товчига // Фармакол. та лікарська токсикол. – 2012. – № 5. – С. 73–78.
Tovchiga, O. Effects of Aegopodium podagraria preparations on the metabolic disorders induced in rats by excess fructose combined with hydrochlorothiazide:
the relationship between influence on electrolyte and сarbohydrate metabolism / O. Tovchiga // Int. J. Biochem. Res. Rev. – 2014.
– Vol. 4, № 1. – P. 80–98. doi: 10.9734/ijbcrr/2014/7201
Tovchiga, O. V. Metabolic effects of goutweed (Aegopodium podagraria L.) tincture and metformin in dexamethasone–treated rats / O. V. Tovchiga //
Pharmac. Sci. and Technol. – 2016. – Vol. 1, № 4. – P. 11–20.
Tovchiga, O. V. The influence of goutweed (Aegopodium podagraria L.) tincture and metformin on the carbohydrate and lipid metabolism in dexamethasone–treated rats / O. V. Tovchiga // BMC Complementary and Alternative Medicine. – 2016. – Vol. 16, Issue 1. – Art. 235. doi: 10.1186/
s12906-016-1221-y
Котюжинская, С. Г. Особенности состояния липидтранспортной системы при экспериментальной гипогепаринемии / С. Г. Котюжинская //
Загальна патол. та патол. фізіол. – 2013. – Т. 8, № 3. – С. 44–49.
A combination of flaxseed oil and astaxanthin alleviates atherosclerosis risk factors in high fat diet fed rats / J. Xu, H. Gao, L. Zhang et al. // Lipids
in Health and Disease. – 2014. – Vol. 13. – Art. 63. doi: 10.1186/1476-511x-13-63
Штрыголь, С. Ю. Модуляция фармакологических эффектов при различных солевых режимах / С. Ю. Штрыголь. – Х. : Ависта–ВЛТ, 2007. – С. 219.
Котюжинская, С. Г. Экспериментальное моделирование атеросклероза: перспективы и трудности / С. Г. Котюжинская, А. И. Гоженко //
Клін. та експерим. патол. – 2014. – № 1 (47). – С. 178–183.
Изменения сосудов головного мозга при экспериментальной гиперлипидемии / Т. С. Гулевская, С. М. Ложникова, А. В. Сахарова и др. //
Бюлл. эксп. биол. мед. – 2000. – № 2. – С. 234–240.
The toxicology of heparin reversal with protamine: past, present and future / E. Sokolowska, B. Kalaska, J. Miklosz, A. Mogielnicki // Expert Opin.
Drug Metab. Toxicol. – 2016. – Vol. 12, Issue 8. – P. 897–909. doi: 10.1080/17425255.2016.1194395
Complexes of a modified low–molecular–weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor–mediated
process in rats / G. Stehle, A. Wunder, H. Sinn et al. // J. Surg. Res. – 1995. – Vol. 58, Issue 2. – P. 197–204. doi: 10.1006/jsre.1995.1031
Evaluation of toxic effects of metformin hydrochloride and glibenclamide on some organs of male rats / O. Adaramoye, O. Akanni, O. Adesanoye et
al. // Niger. J. Physiol. Sci. – 2012. – Vol. 27, Issue 2. – P. 137–144.
Zimmerman, H. J. Oral hypoglycemic agents and other diabetes therapy. // Hepatotoxicity: the adverse effects of drugs and other chemicals on the
liver. – Philadelphia : Lippincott, 1999. – P. 578.
De Marzio, D. H. Biguanides. Hepatotoxicity of cardiovascular and antidiabetic drugs / D. H. De Marzio, V. J. Navarro // Drug–induced liver disease / eds. N. Kaplowitz, L. D. DeLeve. – Amsterdam: Elsevier, 2013. – P. 519–540. doi: 10.1016/c2010-0-68917-6
Kutoh, E. Possible metformin–induced hepatotoxicity / E. Kutoh // Am. J. Geriatr. Pharmacother. – 2005. – Vol. 3, Issue 4. – P. 270–273.
doi: 10.1016/s1543-5946(05)00078-4
Herbal medicine in Mexico: a cause of hepatotoxicity. A critical review / B. Valdivia–Correa, C. Gómez–Gutiérrez, M. Uribe, N. Méndez–Sánchez //
Int. J. Mol. Sci. – 2016. – Vol. 17, Issue 2. – P. 235. doi: 10.3390/ijms17020235
Hepatotoxicity from green tea: a review of the literature and two unpublished cases / G. Mazzanti, F. Menniti–Ippolito, P. A. Moro et al. // Eur. J.
Clin. Pharmacol. – 2009. – Vol. 65, Issue 4. – P. 331–341. doi: 10.1007/s00228-008-0610-7
Cellular and i vivo hepatotoxicity caused by green tea phenolic acids and catechins / G. Galati, A. Lin, A. M. Sultan, P. J. O’Brien // Free Radic. Biol.
Med. – 2006. – Vol. 40, Issue 4. – P. 570–580. doi: 10.1016/j.freeradbiomed.2005.09.014
Use of the Combination Index to determine interactions between plant–derived phenolic acids on hepatotoxicity endpoints in human and
rat hepatoma cells / Y. Liu, T. J. Flynn, M. S. Ferguson, E. M. Hoagland // Phytomedicine. – 2013. – Vol. 20, Issue 5. – P. 461–468. doi: 10.1016/j.
phymed.2012.12.013
Acute exposure of apigenin induces hepatotoxicity in Swiss mice / P. Singh, S. K. Mishra, S. Noel et al. // PLoS One. – 2012. – Vol. 7, Issue 2. –
P. e31964. doi: 10.1371/journal.pone.0031964
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
